Samsung Medical Center
Lung cancer treatment cost in South Korea typically includes essential diagnostics like a PET/CT scan running from AUD $1,414 to AUD $2,262. Primary surgical interventions, such as a lobectomy, cost between AUD $21,493 and AUD $40,440, while a pneumonectomy ranges from AUD $43,692 to AUD $56,136. Total expenses depend on the cancer stage and hospital tier. Australians often save 30–50% compared to private healthcare costs in Australia and the US. Most major treatment centres are located in Seoul and Incheon.
Typical Lung Cancer Treatment Costs in South Korea
Bookimed Expert Insight: For complex cases, patients benefit from large multidisciplinary centres like Asan Medical Centre. This hospital manages over 2,500 inpatients daily, so surgeons handle advanced oncology cases routinely. Patients seeking newer drug protocols should consider specialists like Cho Byung Chul at Severance Hospital. He has specific experience with new clinical drugs for lung cancer chemotherapy. Seoul National University Hospital (SNUH) is another reliable choice with the highest cancer treatment statistics in Korea.
| Republic of Korea | Thailand | Turkey | |
| Proton-beam therapy | from AUD $31,108 | from AUD $127,260 | from AUD $98,980 |
| Pneumonectomy | from AUD $43,622 | from AUD $36,764 | from AUD $15,373 |
| Lung cancer surgery | from AUD $25,311 | from AUD $25,452 | from AUD $24,038 |
| Lobectomy | from AUD $21,531 | from AUD $19,796 | from AUD $10,322 |
| Da Vinci Robotic System | from AUD $16,968 | from AUD $39,592 | from AUD $13,433 |
No hidden fees – just official clinic prices. Pay at the clinic for Lung cancer treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lung cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lung cancer treatment journey.
Professor Choi Yong Soo is a leading thoracic surgeon at the Samsung Medical Center, specialising in surgical interventions for lung tumours.
Professor Cho Byung Chul leads the Oncology Department and specialises in clinical drug trials for lung cancer care.
The 5-year survival rate for lung cancer in the Republic of Korea averages between 30.2% and 34.7%. This figure has doubled over two decades. Major Seoul hospitals report early-stage survival rates between 69% and 82%. These outcomes are supported by robotic surgery and national screening.
Bookimed Expert Insight: Korea's digitalised hospital ecosystem helps prevent medical errors and speeds up treatment. Seoul National University Bundang Hospital was the first fully digital facility. This setup allows oncologists like Dr Cho Byung Chul at Severance Hospital to use new drugs faster than many Western centres.
Patient Consensus: Patients note that Korean hospitals provide rapid access to specialist oncologists. They emphasise that outcomes depend on identifying specific mutations for targeted therapy or immunotherapy early in the diagnostic process.
The Republic of Korea offers lung cancer treatments including proton-beam therapy and robotic-assisted Da Vinci surgery. Leading JCI-accredited centres in Seoul specialise in precision molecular diagnostics and immunotherapy. They use drugs like Keytruda to target specific genetic mutations.
Bookimed Expert Insight: South Korea's oncology sector is highly digitised. Seoul National University Bundang Hospital uses the BESTcare system to reduce medical errors. This digital infrastructure helps doctors like Dr Cho Byung Chul at Severance Hospital manage complex chemotherapy protocols.
Patient Consensus: Patients often highlight the efficiency of the digital hospital systems in Seoul. They appreciate how quickly diagnostic results are shared between surgical and oncology departments.
International patients can access lung cancer clinical trials in South Korea, particularly for phase 2 and 3 global studies. Participation depends on meeting strict diagnostic criteria and biomarker status. Major tertiary centres in Seoul lead these multi-centre pharmaceutical trials.
Bookimed Expert Insight: South Korea ranks 4th globally for medical requests. This huge clinical volume drives trial availability. Leading centres like Samsung Medical Center treat over 2,000,000 patients annually. This high throughput makes Seoul a global hub for recruitment in immunotherapy and targeted therapy trials.
Patient Consensus: Patients note that eligibility depends heavily on biomarker status and recent scans. Travel burdens for frequent monitoring in Seoul are significant. Confirming international participation before departure is vital.
Samsung Medical Center and Asan Medical Center are top choices for lung cancer treatment in South Korea. These facilities hold JCI accreditation and Newsweek rankings. They offer robotic surgery, proton therapy and multidisciplinary care. Most specialists focus on minimally invasive thoracic procedures to improve results.
Bookimed Expert Insight: Many patients focus on the "Big 5" hospitals in Seoul. However, Seoul National University Bundang Hospital is a standout for international patients. It uses the BESTcare digital system to prevent medical errors. This digital focus makes sharing diagnostic images and pathology results with your GP in Australia much simpler.
Patient Consensus: Patients note that South Korean hospitals provide efficient care. They use digital records that make follow-up easier once patients return home.
Most doctors at major South Korean university hospitals speak English. Specialists often train using English medical textbooks and terminology. Facilities like Severance Hospital and Samsung Medical Center have dedicated international clinics. These departments provide English-speaking staff to help during consultations and surgery.
Bookimed Expert Insight: Many specialists are proficient, but high-volume centres like Samsung Medical Center treat over 2,000,000 patients annually. In these fast-paced environments, doctors use precise medical English. Researching a specialist’s experience, such as Dr Choi Yong Soo's work in thoracic surgery, helps keep technical discussions clear.
Patient Consensus: Patients in South Korea suggest confirming if interpreters assist with complex consent forms or discharge instructions. They note that international patient centres help with booking appointments and navigating hospital logistics.